Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprachoroidal Triamcinolone Acetonide in Chorioretinal Diseases
NCT05337332Phase 3Unknown
- Sponsor
- Benha University
- Start
- Apr 2022
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in Central Serous Chorioretinopathy (CSCR), Irvine-Gass syndrome (IGS), sponsored by Benha University. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
Central Serous Chorioretinopathy (CSCR)Irvine-Gass syndrome (IGS)
Beyond the preview
Go deeper on NCT05337332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05337332.